Trials / Completed
CompletedNCT01670773
A Study of CAT-1004 Biomarkers in Healthy Subjects
A Phase 1, Single Center, Biomarker Study in Healthy Subjects Receiving Single Doses of CAT-1004
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Catabasis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to assess mechanistic blood biomarkers of CAT-1004 in healthy humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CAT-1004 | |
| DRUG | Salsalate + DHA | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2012-08-22
- Last updated
- 2012-10-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01670773. Inclusion in this directory is not an endorsement.